Hepatitis C virus NS3/4A protease

Current Opinion in Infectious Diseases

Volumn 10, Issue 6, 1997, Pages 485-490

  Kwong, Ann D ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; PROTEINASE INHIBITOR; RIBAVIRIN; SERINE PROTEINASE; VIRUS ENZYME; VIRUS PROTEIN; ZINC;

DRUG RESEARCH; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; HEPATITIS C; HEPATITIS C VIRUS; METAL BINDING; NONHUMAN; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROCESSING; SHORT SURVEY;

EID: 0030733423     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199712000-00014     Document Type: Short Survey

References (62)

1. Tomei L, Failla C, Santolini E, de Francesco R, La Monica N: NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 1993, 67:4017-4026.
2. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM: A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA 1993, 90:10583-10587.
3. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H: Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Viral 1993, 67:3835-3844.
4. Hong Z, Ferrari E, Wright-Minogue J, Chase R, Risano C, Seelig G, Lee C-G, Kwong AD: Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells using the herpes simplex virus amplicon system. J Virol 1996, 70:4261-4268.
5. Kim DW, Gwack Y, Han JH, Choe J: C-terminal of hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem Biophys Res Commun 1995, 215:160-166.
6. Preugschat F, Averett DR, Clarke BE, Porter DJT: A Steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain. J Biol Chem 1996, 271:24449-24457.
7. Tamura JK, Warrener P, Collett MS: RNA-stimulated NTPase activity associated with the p80 protein of the pestivirus bovine viral diarrhea virus. Virology 1993, 193:1-10.
8. Suzich JA, Tamura JK, Palmer-Hill F, Warrener P, Grakoui A, Rice CM, Feinstone SM, Collett MS: Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol 1993, 67:6152-6158.
9. Morgenstern KA, Landro JA, Hsiao K, Lin C, Yong G, Su MS-S, Thomson JA: Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J Virol 1997, 71:3767-3775 The presence of polynucleotides [particularly poly (U)] modulated the protease, helicase, and NTPase activities of the full-length NS3/4A complex. The authors suggest that the domains within NS3 may influence and regulate each other.
10. Houghton M, Weiner A, Han JH, Kuo G, Choo Q-L: Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991, 14:381-388.
11. Purcell RH: Hepatitis C virus: historical perspective and current concepts. FEMS Microbiol Rev 1994, 14:181-192.
12. Van der Poel CL: Hepatitis C virus. Epidemiology, transmission and prevention. In Current studies in hematology and blood transfusion. Edited by Reesink HW. Basel: Karger; 1994:137-163.
13. Alter MJ, Mast EE: The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994, 23:437-455.
14. Colombo M, Kuo G, Choo Q-L, Donato MF, Ninno ED, Tommasini MA, Dioguardi N, Houghton M: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancelet 1989, 11:1006-1008.
15. Bukh J, Miller RH, Kew MC, Purcell RH: Hepatitis C virus RNA in southen African blacks with hepatocellular carcinoma. Proc Natl Acad Sci USA 1993, 90:1848-1851.
16. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe TY, Koi S, Onji M, Ohta Y, Choo Q-L et al.: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Sci Acad USA 1990, 87:6547-6549.
17. Hollinger FB: Non-A, non-B hepatitis virus. In Virology. Edited by Fields BN. New York: Raven Press; 1990:2239-2273.
18. Houghton M: Hepatitis C viruses. In Virology. Third edn. Edited by Fields BN, Knipe DM, Howley PM. New York: Raven Press; 1996:1035-1058.
19. Kolykhalov AA, Agapov E, Blight KJ, Mihalik K, Feinstone S, Rice CM: Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997, 277:570-574 This study describes the construction of functional HCV cDNA clones. RNA transcribed from the clones was found to be infectious and to cause disease in chimpanzees after direct intrahepatic inoculation.
20. Hino K, Sainokami S, Shimoda K, Lino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M: Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994, 42:299-305.
21. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K: Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994, 19:1088-1094.
22. Main J: Future studies of combination therapy for chronic hepatitis C: optimizing response rate for each hepatitis C population. J Hepatol 1995, 23:32-36.
23. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH: Lack of protective immunity against reinfection with hepatitis C virus. Science 1992, 258:135-140.
24. Ogata N, Alter HJ, Miller RH, Purcell RH: Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991, 88:3392-3396.
25. Kaito M, Watanabe S, Tsukiyama-Kohara K, Yamaguchi K, Kobayashi Y, Konishi M, Yokoi M, Ishida S, Suzuki S, Kohara M: Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994, 75:1755-1760.
26. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM: Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993, 67:1385-1395.
27. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K: Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 1991, 88:5547-5551.
28. Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM: Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol 1994, 68:5063-5073.
29. Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ, Rice CM: Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci USA 1990, 87:8898-8902.
30. Love RA, Parge HE, Wickersham JA, Hostomsky Z, Habuka N, Moomaw EW, Adachi T, Hostomska Z: The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 1996, 87:331-342 The structure of the NS3 protease domain in the absence of the NS4A activator was determined by X-ray crystallography at 2.4Å resolution.
31. Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley ET et al.: Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 1996, 87:343-355 The structure of the NS3 protease domain in the presence of a synthetic NS4A activator peptide was determined by X-ray crystallography at 2.5Å resolution.
32. ••].
33. Satoh S, Tanji Y, Hijikata M, Kimura K, Shimotohno K: The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J Virol 1995, 69:4255-4260.
34. Failla C, Tomei L, De Francesco R: An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol 1995, 69:1769-1777.
35. Bartenschlager R, Lohmann V, Wilkinson T, Koch JO: Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol 1995, 69:7519-7528.
36. Butkiewicz N, Wendel M, Zhang R, Jubin R, Pichardo J, Smith EB, Hart AM, Ingram R, Durkin J, Mui PW et al.: Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity. Virology 1996, 225:328-338.
37. Lin C, Thomson JA, Rice CM: A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol 1995, 69:4373-4380.
38. Shimizu Y, Yamaji K, Masuho Y, Yokota T, Inoue H, Sudo K, Satoh S, Shimotohno K: Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J Virol 1996, 70:127-132.
39. Tanji Y, Hijikata M, Satoh S, Kaneko T, Shimotohno K: Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol 1995, 69:1575-1581.
40. Steinkuhler C, Urbani A, Tomei L, Biasiol MS, Bianchi E, Pessi A, De Francesco R: Activity of purified hepatitis C virus protease NS3 on peptide substrates. J Virol 1996, 70:6694-6700 The activity of the NS3 protease domain was optimized and the cleavage kinetics on peptides corresponding to the different trans-cleavage sites in the HCV polyprotein was examined.
41. Bianchi E, Urbani A, Biasiol G, Brunetti M, Pessi A, De Francesco R, Steinkuhler C: Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide. Biochemistry 1997, 36:7890-7897 The effect of NS4A peptide binding to NS3 was examined by far and near-ultraviolet circular dichronism spectrum analysis.
42. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM: Characterization of the hepatitis C virus-encoded serine proteinase: determination of the proteinase-dependent polyprotein cleavage sites. J Virol 1993, 67:2832-2843.
43. Failla CM, Pizzi E, De Francesco R, Tramontano A: Redesigning the substrate specificity of the hepatitis C virus NS3 protease. Folding Design 1996, 1:35-42.
44. Pizzi E, Tramontano A, Tomei L, La Monica N, Failla C, Sardana M, Wood T, De Francesco R: Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition. Proc Natl Sci Acad USA 1994, 91:888-892.
45. Urbani A, Bianchi E, Narjes F, Tramontano A, De Francesco R, Steinkuhler C, Pessi A: Substrate specificity of the hepatitis C virus serine protease NS3. J Biol Chem 1997, 272:9204-9209. Natural and non-natural amino acid modifications were introduced into peptides derived from the NS4A/NS4B cleavage site. Kinetic analyses in the presence and absence of a NS4A activator peptide and the NS3 protease domain were determined.
46. m values. A stringent stereochemical requirement for the native P1 Cys in the S1 pocket was observed-alteration of the sulfhydryl function and/or the steric characteristics (bulkiness or chirality) resulted in a 20- to 12 500-fold loss of cleavage efficiency.
47. Hahm B, Han DS, Back SH, Song O-K, Cho M-J, Kim C-J, Shimotohno K, Jang SK: NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J Virol 1995, 69:2534-2539.
48. D'Souza EDA, Grace K, Sangar DV, Rowlands DJ, Clarke BE: In vitro cleavage of hepatitis C virus polyprotein substrates by purified recombinant NS3 protease. J Gen Virol 1995, 76:1729-1736.
49. Lin C, Rice CM: The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Proc Natl Acad Sci USA 1995, 92:7622-7626.
50. Markland W, Petrillo RA, Fitzgibbon M, Fox T, McCarrick R, McQuaid T, Fulghum JR, Chen W, Fleming MA, Thompson JA, Chambers SP: Purification and characterization of the NS3 serine protease domain of hepatitis C virus expressed in Saccharomyces cerevisiae. J Gen Virology 1997, 78:39-43.
51. Bouffard P, Bartenschlager R, Ahlborn-Laake L, Mous J, Roberts N, Jacobsen H: An in vitro assay for hepatitis C virus NS3 serine proteinase. Virol 1995, 209:52-59.
52. De Francesco R, Urbani A, Nardi MC, Tomei L, Steinkuhler C, Tramontano A: A zinc binding site in viral serine proteinase. Biochemistry 1996, 35:13282-13287.
53. Stempniak M, Hostomska Z, Nodes BR, Hostomsky Z: The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme. J Virol 1997, 71:2881-2886.
54. Hans DS, Hahm B, Rho H-M, Jang SK: Identification of the protease domain in NS3 of hepatitis C virus. J Gen Virol 1995, 76:985-993.
55. Bazen JF, Fletterick RJ: Viral cysteine proteases are homologous to the trypsin-like family of serine protease: structural and functional implications. Proc Natl Acad Sci USA 1988, 85:7872-7876.
56. Yu SF, Loyd RE: Characterization of the roles of conserved cysteine and histidine residues in poliovirus 2A protease. Virology 1992, 186:725-735.
57. Voss T, Meyer R, Sommergruber W: Spectroscopic characterization of rhinoviral protease 2A: Zn is essential for the structural integrity. Protein Sci 1995, 4:2256-2531.
58. Sommergruber W, Casari G, Fessl F, Seipelt J, Skern T: The 2A proteinase of human rhinovirus is a zinc containing enzyme. Virology 1994, 204:815-818.
59. Lin C, Pragai BM, Grakoui A, Xu J, Rice CM: Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol 1994, 68:8147-8157.
60. Yoshikura H, Hijikata M, Nakajima N, Shimizu YK: Replication of hepatitis C virus. J Viral Hepatitis 1996, 3:3-10.
61. Filocamo G, Pacini L, Migliaccio G: Chimeric sindbis viruses dependent on the NS3 protease of hepatitis C virus. J Virol 1997, 71:1417-1427.
62. Hahm B, Back SH, Lee TG, Wimmer E, Jang SK: Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity. Virology 1996, 226:318-326.